Melanie Cerullo 

Chief Quality & Regulatory Officer

  •  mRNA innovators who are developing the industry’s first truly continuous and integrated mRNA manufacturing platform through: 
  •  Advanced PAT and leading-edge process technologies: 
    • AI-driven process development 
    • AI-enhanced continuous mRNA manufacturing 
    • Real-time drug product release 
  • State-of-the-art process and analytical development and CGMP manufacturing services for plasmid, mRNA, and LNP within a single facility. 
  • We are a CDMO manufacturing clinical and commercial ATMPs with sites in the US and Europe.
  • Flexible and customer centric, offering CMC expertise and comprehensive solutions to customer’s unique needs.